Slideshow

8 Reasons a Psychotropic Medication May Be Discontinued

Author(s):

John J. Miller, MD

Tips for having a balanced and comprehensive risk-to-benefit discussion with competent patients who want to stop their medications.

This article was originally posted on January 28, 2015 and has since been updated.

Related Videos
Tierney/AdobeStock
Julyuela/AdobeStock
bipolar
schizophrenia
2025
bipolar
bipolar
Erin Crown, PA-C, CAQ-Psychiatry, and John M. Kane, MD, experts on schizophrenia
nicotine use
brain schizophrenia
Related Content
bipolar
March 4th 2025

BHV-7000 for Bipolar Disorder Fails in Phase 2/3 Trial

Leah Kuntz
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
Stephen McLeod-Bryant, MD
February 28th 2025

Learning How to Actively Listen: In Conversation With Stephen McLeod-Bryant, MD

Leah Kuntz Stephen McLeod-Bryant, MD
Blue Light, Depression, and Bipolar Disorder
August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
catatonia
February 26th 2025

Diagnosis and Management of Catatonia via Telepsychiatry: Case Series and Guide for Clinical Practice

Sharvari Shivanekar, MD Roberto León-Barriera, MD Priya Gopalan, MD
bipolar
February 25th 2025

FDA Accepts sNDA for Uzedy Extended-Release Injectable Suspension for Bipolar I Disorder

Leah Kuntz
© 2025 MJH Life Sciences

All rights reserved.